What is the BMGL stock price prediction for next 2 weeks?

According to our price prediction algorithm,Basel Medical Group Ltd Ordinary Shares (BMGL) price will be around $0.52 in the next 2 weeks. This means it will decrease by -11.237288135593207 from the last closing price. This prediction may vary from other time period filters for BMGL stock.

What can be the highest Possible price of BMGL stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, BMGL can achieve the highest price of $0.58 which is -1.1091157411309585 lower than last closing price. This prediction may vary from other time period filters for BMGL stock.

What can be the lowest Possible price of BMGL stock in next 2 weeks?

As per the forecast and algorithmic analysis, BMGL stock price can be as low as $0.46 which is -22.30744410727764 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for BMGL stock.

Will BMGL stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that BMGL stock will lose-11.237288135593207 in the next 2 weeks. This prediction may vary from other time period filters for BMGL stock.

What is BMGL stock last closing price?

Last closing price of BMGL stock was $0.59.

What is BMGL stock price prediction?

BMGL stock price prediction means predicting the future closing prices of BMGL stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of BMGL stock in a certain time period.

How we predict BMGL stock future prices?

If you are searching for BMGL stock forecast, analysis or price prediction, then you might be wondering what Basel Medical Group Ltd Ordinary Shares (BMGL) will do in the future. Our BMGL price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This BMGL price prediction will likely answer most of your questions.

How frequent we update BMGL stock predictions?

We are updating the forecasts for the BMGL stock on daily basis.

Is using ML forecasting for BMGL stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for BMGL stock same for all the time periods?

No, the prediction for BMGL stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Basel Medical Group Ltd Ordinary Shares Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.59-7.8%Since 2 Weeks

Predicted Price$0.52-11.24%For 2 Weeks

Upper Predicted Price$0.58-1.11%For 2 Weeks

Lower Predicted Price$0.46-22.31%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of BMGL will decline by -11.24% over the next 2 Weeks and hit $0.52 by Friday, March 20, 2026. In that time frame, BMGL's share price is expected to range between $0.46 and $0.58.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Mar 20, 2026	0.46	0.52	0.58
Mar 19, 2026	0.48	0.55	0.61
Mar 18, 2026	0.48	0.53	0.60
Mar 17, 2026	0.47	0.53	0.59
Mar 16, 2026	0.47	0.54	0.60
Mar 13, 2026	0.49	0.56	0.62
Mar 12, 2026	0.52	0.58	0.64
Mar 11, 2026	0.50	0.57	0.63
Mar 10, 2026	0.50	0.56	0.63
Mar 9, 2026	0.51	0.58	0.64

BMGL shares fell -1.42% in Friday, March 6, 2026's trading session, dropping from a previous close of $0.60 to move at $0.59. The stock demonstrated notable intraday movement (see BMGL's key stats for a full breakdown), fluctuating between $0.57 and $0.59, a +3.47% trading range. While recent weeks have seen some volatility, BMGL has managed to secure a -13.26% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 5.85K shares changing hands, 4.81K fewer than the previous session. This amounted to $3.45K in total market activity.

Will BMGL Continue Its Downward Trend?

According to analyst ratings and projections for BMGL, Basel Medical Group Ltd Ordinary Shares shares are anticipated to decrease by -1.12%, potentially reaching $0.58 per share by March 20, 2026. Short-term technical indicators currently suggest a neutral sentiment for BMGL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the BMGL stock forecast, now is not the best time to buy BMGL stock because its current trading price is +12.66% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BMGL covering social and institutional perspectives.

BMGL Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into BMGL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.29% to 41.71%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 41.89%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.05%, maintains a neutral outlook for the long term. Insights into BMGL's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Basel Medical Group Ordinary Shares Short-Term Forecasts

BMGL Forecast For Next 5 Days

Our algorithm anticipates Basel Medical Group Ordinary Shares (BMGL) stock could hit $0.59 by Mar 13, 2026. This represents a +0.27% rise from today's price, following a +17.47% change over the past five days.

BMGL Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Basel Medical Group Ltd Ordinary Shares (BMGL) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.62, which would mean a +5.08% increase from the current price of $0.59. Projections for this period range from a high of $0.82 to a low of $0.40.

BMGL Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Basel Medical Group Ordinary Shares's price over the next three months point to a rise. BMGL stock is expected to peak at $2.37 on Mar 09, 2026 before potentially dipping to $0.34 on May 20, 2026. On average, BMGL is likely to trade around $1.31 in the coming 90 days.

Basel Medical Group Ordinary Shares Stock Forecast 2025

Based on our predictive models, Basel Medical Group Ordinary Shares (BMGL) is expected to trade between $0.02 and $2.37 throughout 2026. This would result in an average price of $0.73, potentially offering investors a +23.73% return from current levels.

Basel Medical Group Ltd Ordinary Shares Monthly Forecast 2026–2027

March 2026

According to our latest forecast models, Basel Medical Group Ltd Ordinary Shares (BMGL) is positioned to show a strong performance in March 2026. The price is predicted to move between $1.26 and $2.37, settling at an average of $1.76. This could translate to a +198.31% gain.

April 2026

Based on current market signals, Basel Medical Group Ltd Ordinary Shares is projected to trend april 2026. We forecast a trading range from $1.14 to $2.24, with a likely average price of $1.51. Investors could expect a potential return of +155.93%.

May 2026

Our predictive algorithms indicate Basel Medical Group Ltd Ordinary Shares stock may see a shift in May 2026. The expected range spans $0.34–$1.44, with an average target of $0.82. This represents a positive outlook and a possible gain of +38.98%.

June 2026

Analyzing established trends, Basel Medical Group Ltd Ordinary Shares looks set to move in June 2026. Projections place the stock between $0.50 and $1.17, averaging around $0.82. This suggests a +38.98% gain from current levels.

July 2026

Market indicators suggest Basel Medical Group Ltd Ordinary Shares could experience notable changes during July 2026. Prices could fluctuate within $0.54 to $0.96, with a midpoint forecast of $0.73. The stock might deliver a +23.73% gain.

August 2026

Forecasting for August 2026, models estimate that Basel Medical Group Ltd Ordinary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.26 and $0.88, averaging $0.56. This signals a cautious trajectory with potential returns around -5.08%.

September 2026

According to our latest forecast models, Basel Medical Group Ltd Ordinary Shares (BMGL) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.25 and $0.70, settling at an average of $0.45. This could translate to a -23.73% loss.

October 2026

Based on current market signals, Basel Medical Group Ltd Ordinary Shares is projected to trend october 2026. We forecast a trading range from $0.17 to $0.54, with a likely average price of $0.36. Investors could expect a potential return of -38.98%.

November 2026

Our predictive algorithms indicate Basel Medical Group Ltd Ordinary Shares stock may see a shift in November 2026. The expected range spans $0.11–$0.51, with an average target of $0.31. This represents a cautious outlook and a possible loss of -47.46%.

December 2026

Analyzing established trends, Basel Medical Group Ltd Ordinary Shares looks set to move in December 2026. Projections place the stock between $0.02 and $0.45, averaging around $0.23. This suggests a -61.02% loss from current levels.

January 2027

Market indicators suggest Basel Medical Group Ltd Ordinary Shares could experience notable changes during January 2027. Prices could fluctuate within $0.02 to $0.34, with a midpoint forecast of $0.18. The stock might deliver a -69.49% loss.

February 2027

Forecasting for February 2027, models estimate that Basel Medical Group Ltd Ordinary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.29, averaging $0.13. This signals a cautious trajectory with potential returns around -77.97%.

March 2027

According to our latest forecast models, Basel Medical Group Ltd Ordinary Shares (BMGL) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $0.22, settling at an average of $0.10. This could translate to a -83.05% loss.

BMGL's history of dividends and stock splits also plays a role in long-term investor confidence.